SCHEMBL7557708

SCHEMBL7557708

N#CC1CCN(CCn2cc(-c3cncc(-c4ccsc4)c3)c3ncccc32)CC1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDR P35968 9/20 0.56
FLT1 P17948 4/20 0.56
FLT4 P35916 4/20 0.56
CYP2A6 P11509 3/20 0.36
RPS6KB1 P23443 1/20 0.33
AKT1 P31749 1/20 0.33
GSK3B P49841 2/20 0.33
MAOB P27338 1/20 0.33
CALCRL Q16602 2/20 0.32
HTR7 P34969 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2B6 P20813 1/20 0.32
CYP2C19 P33261 1/20 0.32
DRD2 P14416 1/20 0.32
DRD4 P21917 1/20 0.32
DRD3 P35462 1/20 0.32
NFATC1 O95644 1/20 0.31
DYRK1A Q13627 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7548014 0.89 KDR (0.43) KDRFLT1FLT4GSK3BDRD2
SCHEMBL7546102 0.87 KDR (0.75) KDRFLT1FLT4CYP2A6GSK3B
SCHEMBL7993940 0.87 KDR (0.74) KDRFLT1FLT4CYP2A6GSK3B
SCHEMBL7553729 0.86 KDR (0.40) KDRFLT1FLT4GSK3BDRD4
SCHEMBL7990540 0.86 KDR (0.75) KDRFLT1FLT4CYP2A6GSK3B
SCHEMBL7553655 0.85 KDR (0.39) KDRFLT1FLT4RPS6KB1AKT1
SCHEMBL7994055 0.84 KDR (0.56) KDRFLT1FLT4CYP2A6RPS6KB1
SCHEMBL7551721 0.84 CHRNB1 (0.39) KDRFLT1FLT4GSK3BMAOB
SCHEMBL7549687 0.83 AVPR1B (0.38) KDRFLT1FLT4CYP3A4DRD2
SCHEMBL7990489 0.81 KDR (0.75) KDRFLT1FLT4CYP2A6GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed